Bönig, H., Verbeek, M., Herhaus, P., Braitsch, K., Beutel, G., Schmid, C., . . . Bader, P. (2024). Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease: Correction. Journal of translational medicine, 22, . https://doi.org/10.1186/s12967-024-05348-8
Chicago-Zitierstil (17. Ausg.)Bönig, Halvard, et al. "Correction: Real‑world Data Suggest Effectiveness of the Allogeneic Mesenchymal Stromal Cells Preparation MSC‑FFM in Ruxolitinib‑refractory Acute Graft‑versus‑host Disease: Correction." Journal of Translational Medicine 22 (2024). https://doi.org/10.1186/s12967-024-05348-8.
MLA-Zitierstil (9. Ausg.)Bönig, Halvard, et al. "Correction: Real‑world Data Suggest Effectiveness of the Allogeneic Mesenchymal Stromal Cells Preparation MSC‑FFM in Ruxolitinib‑refractory Acute Graft‑versus‑host Disease: Correction." Journal of Translational Medicine, vol. 22, 2024, https://doi.org/10.1186/s12967-024-05348-8.